Corpus ID: 41775056

Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis

@article{Hu2017RelationshipOM,
  title={Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis},
  author={Hong Hu and Yong Fang and Xiao-yun Zhou and L. Gong and Li-Li Liu and W. Wang and Jiping Sun and C. Zhai and H. Pan and Yong Dong},
  journal={Biomedical Research-tokyo},
  year={2017},
  volume={28},
  pages={4439-4444}
}
Aims: This study is to systematically investigate the relationship between metformin and risk of pancreatic cancer in patients with type 2 diabetes mellitus. Methods: A systematic literature search was performed on PubMed, Embase, Cochrane Library, Highwire, CBM, CNKI, Wanfang, VIP databases. Cohort or case control studies of metformin and risk of pancreatic cancer in patients with type 2 diabetes mellitus were included. The Newcastle-Ottaua Scale score was used for quality evaluation and meta… Expand
3 Citations
The Potential Effect of Metformin on Cancer: An Umbrella Review
Pancreatic Cancer and Diabetes Mellitus

References

SHOWING 1-10 OF 43 REFERENCES
Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies.
Association of metformin use with cancer incidence and mortality: a meta-analysis.
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Antidiabetic therapies affect risk of pancreatic cancer.
...
1
2
3
4
5
...